V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310002788 | 310006452 | 1.68 | 70.5 | Palliative (P) | 2017-09-19 | 2017-10-11 | PEMBROLIZUMAB | N | N | 310016150 | PEMBROLIZUMAB |
| 310002789 | 310006452 | 1.76 | 12.8 | Palliative (P) | 2013-09-26 | 2013-09-26 | Carboplatin + Etoposide iv&po | N | N | 310016150 | CARBOPLATIN + ETOPOSIDE |
| 310002790 | 310006452 | null | 67.999 | Palliative (P) | 2017-05-07 | 2017-05-15 | PEMBROLIZUMAB | 02 | N | 310016150 | PEMBROLIZUMAB |
| 310002791 | 310006452 | 1.87 | 72 | Curative (C) | 2017-09-07 | 2017-09-10 | CHOP R - 21 days | 02 | N | 310016150 | CHOP R |
| 310002797 | 310001188 | 1.65 | 60 | Neo-adjuvant (N) | 2015-06-28 | 2015-07-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016176 | CISPLATIN + GEMCITABINE |
| 310002798 | 310001189 | 1.8 | null | Palliative (P) | 2014-02-18 | 2014-02-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310016177 | CISPLATIN + GEMCITABINE |
| 310002799 | 310001189 | 1.56 | 5.3 | Curative (C) | 2017-11-11 | 2017-12-05 | Cisplatin 7 day | N | Y | 310016177 | CISPLATIN |
| 310002800 | 310008954 | 1.7 | 84.4 | Palliative (P) | 2014-07-24 | 2014-08-02 | PEMBROLIZUMAB | 02 | N | 310016187 | PEMBROLIZUMAB |
| 310002801 | 310010277 | 1.57 | 89 | Palliative (P) | 2017-05-24 | 2017-06-07 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | 2 | 310016191 | CISPLATIN + GEMCITABINE |
| 310002802 | 310010277 | 1.66 | 51.8 | Palliative (P) | 2013-07-15 | 2013-07-18 | Doxorubicin 75mg/m2 | N | null | 310016191 | DOXORUBICIN |
| 310002805 | 310001191 | 0 | 15 | Curative (C) | 2013-02-03 | 2013-02-23 | Retinoblastoma JOE | N | N | 310016208 | CEV |
| 310002806 | 310006455 | null | 65.1 | Not known (9) | 2016-04-12 | 2016-04-13 | Ipilimumab | 02 | N | 310016209 | IPILIMUMAB |
| 310002807 | 310006455 | null | 46 | Adjuvant (A) | null | 2017-04-13 | Cisplatin 7 day | N | Y | 310016209 | CISPLATIN |
| 310002808 | 310001192 | 1.56 | 57.3 | Curative (C) | 2016-06-24 | 2016-06-28 | Cisplatin 7 day | Y | N | 310016217 | CISPLATIN |
| 310002809 | 310006456 | 1.7 | 99.9 | Neo-adjuvant (N) | 2017-06-24 | 2017-06-26 | Cisplatin+Gemcitabine (Days 1&8&15) | 02 | null | 310016219 | CISPLATIN + GEMCITABINE |
| 310002810 | 310001193 | 1.75 | 90.5 | Palliative (P) | 2013-12-30 | 2014-01-16 | Carboplatin + Etoposide iv&po | 02 | N | 310016224 | CARBOPLATIN + ETOPOSIDE |
| 310002811 | 310001193 | 0 | null | Adjuvant (A) | 2014-09-10 | 2014-09-10 | Retinoblastoma JOE | N | N | 310016224 | CEV |
| 310002812 | 310001193 | 1.86 | 81.7 | Curative (C) | 2015-06-14 | 2015-06-15 | Cisplatin 7 day | 02 | Y | 310016224 | CISPLATIN |
| 310002813 | 310001193 | 1.69 | 93.1 | Palliative (P) | null | 2019-02-06 | Doxorubicin 75mg/m2 | N | N | 310016224 | DOXORUBICIN |
| 310002814 | 310001194 | 1.69 | 71.15 | Disease modification (D) | 2015-06-29 | 2015-06-29 | CISPLATIN + GEMCITABINE | 02 | N | 310016232 | CISPLATIN + GEMCITABINE |
| 310002815 | 310006458 | 1.56 | 70 | Palliative (P) | 2015-02-26 | 2015-03-11 | PEMBROLIZUMAB | N | N | 310016234 | PEMBROLIZUMAB |
| 310002816 | 310006458 | 1.83 | null | Palliative (P) | 2017-07-11 | 2017-07-15 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310016234 | CISPLATIN + GEMCITABINE |
| 310002817 | 310001195 | 1.66 | 81 | Palliative (P) | 2015-05-05 | 2015-05-13 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 310016247 | CISPLATIN + GEMCITABINE |
| 310002818 | 310001196 | 0 | 97.3 | Palliative (P) | 2015-11-18 | 2016-05-22 | CHEMO-T TRIAL | Y | N | 310016251 | TRIAL |
| 310002819 | 310006459 | 1.75 | 59 | Palliative (P) | 2013-08-03 | 2013-08-03 | Carboplatin + Etoposide IV 3 day | 02 | null | 310016252 | CARBOPLATIN + ETOPOSIDE |
| 310002820 | 310001197 | null | 70.2 | Curative (C) | 2013-04-06 | 2013-04-06 | Retinoblastoma JOE | N | N | 310016264 | CEV |
| 310002821 | 310001197 | null | 76.2 | Palliative (P) | 2016-04-24 | 2016-05-08 | PEMBROLIZUMAB | N | N | 310016264 | PEMBROLIZUMAB |
| 310002822 | 310001198 | 1.8 | null | Curative (C) | 2015-02-16 | 2015-02-16 | Trial Unspecified | Y | N | 310016270 | TRIAL |
| 310002823 | 310001199 | 1.69 | 10.6 | null | 2014-05-07 | 2014-05-07 | CISPLATIN + GEMCITABINE | 2 | N | 310016271 | CISPLATIN + GEMCITABINE |
| 310002824 | 310001200 | null | 54 | Palliative (P) | 2017-08-21 | 2017-08-23 | CHEMO-T TRIAL | 01 | N | 310016273 | TRIAL |
| 310002825 | 310001200 | 1.76 | 81 | Curative (C) | 2017-03-29 | 2017-03-31 | PEMBROLIZUMAB | 02 | N | 310016273 | PEMBROLIZUMAB |
| 310002826 | 310001201 | 1.68 | 85 | Palliative (P) | 2014-03-04 | 2014-03-20 | PEMBROLIZUMAB | N | N | 310016281 | PEMBROLIZUMAB |
| 310002827 | 310001202 | 1.7 | 113 | null | 2017-12-02 | 2017-12-22 | CHOP R - 21 days | 2 | N | 310016282 | CHOP R |
| 310002828 | 310001202 | 1.59 | null | Palliative (P) | 2013-05-03 | 2013-05-15 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310016282 | CISPLATIN + GEMCITABINE |
| 310002829 | 310001203 | null | 53.9 | Curative (C) | 2014-12-06 | 2014-12-22 | Cisplatin | 02 | Y | 310016301 | CISPLATIN |
| 310002830 | 310001204 | 1.77 | 110.6 | null | 2013-08-10 | 2013-09-01 | CHOP R - 21 days | N | N | 310016303 | CHOP R |
| 310002831 | 310001205 | 1.7 | 76 | Palliative (P) | 2015-12-21 | 2015-12-28 | Ipilimumab | 02 | N | 310016304 | IPILIMUMAB |
| 310002832 | 310001206 | 1.63 | 71.9 | Palliative (P) | 2018-07-24 | 2018-07-24 | PEMBROLIZUMAB | 02 | N | 310016307 | PEMBROLIZUMAB |
| 310002833 | 310001206 | 1.56 | null | Palliative (P) | 2015-01-25 | 2015-02-02 | CISPLATIN + GEMCITABINE | 02 | N | 310016307 | CISPLATIN + GEMCITABINE |
| 310002834 | 310001207 | null | 57.8 | Curative (C) | null | 2016-07-30 | Cisplatin + Gemcitabine (D 1 & 8) | null | 2 | 310016318 | CISPLATIN + GEMCITABINE |
| 310002835 | 310001207 | 1.64 | 86 | Palliative (P) | 2018-01-04 | 2018-01-08 | Ipilimumab | 02 | N | 310016318 | IPILIMUMAB |
| 310002836 | 310001208 | 1.73 | 89 | Palliative (P) | 2015-05-06 | 2015-05-20 | CARBOPLATIN + ETOPOSIDE | N | N | 310016328 | CARBOPLATIN + ETOPOSIDE |
| 310002837 | 310001208 | 0.94 | 101 | Curative (C) | 2017-06-25 | 2017-06-25 | Retinoblastoma JOE | N | N | 310016328 | CEV |
| 310002838 | 310001208 | null | null | Palliative (P) | null | 2017-11-17 | CARBOPLATIN + ETOPOSIDE | N | N | 310016328 | CARBOPLATIN + ETOPOSIDE |
| 310002839 | 310001209 | 1.7 | null | Palliative (P) | 2018-10-13 | 2018-11-03 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310016343 | CISPLATIN + GEMCITABINE |
| 310002841 | 310001211 | 0.75 | 69 | Not known (9) | 2015-01-30 | 2015-02-06 | Trial Unspecified | N | N | 310016352 | TRIAL |
| 310002842 | 310001211 | 1.54 | 65.1 | Curative (C) | 2014-01-29 | 2014-04-05 | Cisplatin | N | N | 310016352 | CISPLATIN |
| 310002843 | 310001212 | 1.87 | 75.5 | Curative (C) | 2015-12-20 | 2015-12-30 | CHOP R | N | N | 310016356 | CHOP R |
| 310002844 | 310006467 | 1.54 | 74 | null | 2014-09-30 | 2014-10-02 | CARBOPLATIN + ETOPOSIDE | N | N | 310016360 | CARBOPLATIN + ETOPOSIDE |
| 310002845 | 310001213 | 1.85 | 112.2 | Neo-adjuvant (N) | 2015-04-01 | 2015-04-05 | CISPLATIN + GEMCITABINE | 02 | N | 310016362 | CISPLATIN + GEMCITABINE |